DelveInsight Analyzes NK Cell Therapy Pipeline for 2026

Report examines 160+ therapies in development by over 140 companies

Apr. 10, 2026 at 3:00pm

Got story updates? Submit your updates here. ›

A glowing, neon-like outline of a human cell with intricate, pulsing lines representing the internal structures and pathways of a natural killer cell, set against a dark background and conveying the energy and dynamism of this specialized immune cell.The vibrant, neon-lit outline of a natural killer cell illustrates the potential of this powerful immune therapy to fight cancer.Las Vegas Today

According to a new report by DelveInsight, the global pipeline for NK (natural killer) cell therapies consists of over 160 therapies in development by more than 140 key companies. The analysis covers the current state of NK cell therapy clinical trials, mechanisms of action, routes of administration, and ongoing developments in this rapidly advancing field of cancer treatment.

Why it matters

NK cell therapies represent a promising new frontier in immunotherapy, harnessing the body's natural defenses to target and destroy cancer cells. As the pipeline continues to expand, understanding the latest advancements in this space is crucial for healthcare providers, researchers, and patients seeking innovative treatment options.

The details

DelveInsight's comprehensive report examines the current NK cell therapy pipeline, providing insights into the various mechanisms of action, routes of administration, and key clinical trial updates for the 160+ therapies in development. The analysis covers both autologous (using a patient's own cells) and allogeneic (using donor cells) NK cell therapies targeting a range of cancer types.

  • The report was published on April 10, 2026.

The players

DelveInsight

A leading healthcare consulting and market research firm that provides comprehensive industry analysis and reports on various medical fields, including the NK cell therapy pipeline.

Got photos? Submit your photos here. ›

What’s next

The report is available for purchase through DelveInsight's website, providing healthcare professionals, researchers, and investors with detailed insights into the evolving NK cell therapy landscape.

The takeaway

As the field of NK cell therapy continues to advance, this comprehensive report from DelveInsight offers a valuable resource for understanding the current state of the pipeline, potential treatment options, and the ongoing progress in this promising area of cancer research and care.